In the golden age of pharmaceutical nanocarriers, we are witnessing a maturation stage of
the original concepts and ideas. There is no doubt that nanoformulations are extremely …

Abstract Solid Lipid Nanoparticles (SLN), the first type of lipid-based solid carrier systems in
the nanometer range, were introduced as a replacement for liposomes. SLN are aqueous …

Colloidal systems based on lipids have attracted attention during the last two decades as a
delivery method of drugs that are poorly soluble in water. The investigations carried out have …

Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have opened new
horizons in the pharmaceutical industry since they play a fundamental role in the field of …

Lipid nanoparticles have attracted significant interests in the last two decades, and have
achieved tremendous clinical success since the first clinical approval of Doxil in 1995. At the …

Introduction: Nanoparticles are rapidly developing as drug carriers because of their size-
dependent properties. Lipid nanoparticles (LNPs) are widely employed in drug delivery …

Solid lipid nanoparticles are at the forefront of the rapidly developing field of nanotechnology
with several potential applications in drug delivery, clinical medicine, and research, as well …

In the era of nanoparticulate controlled and site specific drug delivery systems, use of solid
lipids to produce first generation lipid nanoparticles, solid lipid nanoparticles (SLN), became …

Solid lipid nanoparticles are at the forefront of the rapidly developing field of nanotechnology
with several potential applications in drug delivery, clinical medicine and research, as well …

The lipids are a large group of organic compounds that has a fundamental role in life on
Earth. Whether they act as the energy storage in our bodies or as the building blocks of the …